Literature DB >> 17942131

Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening.

Kirsten A Baken1, Jeroen L A Pennings, Martijs J Jonker, Mirjam M Schaap, Annemieke de Vries, Harry van Steeg, Timo M Breit, Henk van Loveren.   

Abstract

In order to investigate immunotoxic effects of a set of model compounds in mice, a toxicogenomics approach was combined with information on macroscopical and histopathological effects on spleens and on modulation of immune function. Bis(tri-n-butyltin)oxide (TBTO), cyclosporin A (CsA), and benzo[a]pyrene (B[a]P) were administered to C57BL/6 mice at immunosuppressive dose levels. Acetaminophen (APAP) was included in the study since indications of immunomodulating properties of this compound have appeared in the literature. TBTO exposure caused the most pronounced effect on gene expression and also resulted in the most severe reduction of body weight gain and induction of splenic irregularities. All compounds caused inhibition of cell division in the spleen as shown by microarray analysis as well as by suppression of lymphocyte proliferation after application of a contact sensitizer as demonstrated in an immune function assay that was adapted from the local lymph node assay. The immunotoxicogenomics approach applied in this study thus pointed to immunosuppression through cell cycle arrest as a common mechanism of action of immunotoxicants, including APAP. Genes related to cell division such as Ccna2, Brca1, Birc5, Incenp, and Cdkn1a (p21) were identified as candidate genes to indicate anti-proliferative effects of xenobiotics in immune cells for future screening assays. The results of our experiments also show the value of group wise pathway analysis for detection of more subtle transcriptional effects and the potency of evaluation of effects in the spleen to demonstrate immunotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942131     DOI: 10.1016/j.taap.2007.08.026

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Blood gene expression profiling of an early acetaminophen response.

Authors:  P R Bushel; R D Fannin; K Gerrish; P B Watkins; R S Paules
Journal:  Pharmacogenomics J       Date:  2016-03-01       Impact factor: 3.550

2.  Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in Rats.

Authors:  Xiaoyan Lu; Bin Hu; Jie Zheng; Cai Ji; Xiaohui Fan; Yue Gao
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

Review 3.  Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.

Authors:  Jamie C DeWitt; Dori R Germolec; Robert W Luebke; Victor J Johnson
Journal:  Curr Protoc Toxicol       Date:  2016-02-01

4.  RNA-Seq-Based Gene Expression Pattern and Morphological Alterations in Chick Thymus during Postnatal Development.

Authors:  Zhouyiyuan Xue; Abdur Rahman Ansari; Xing Zhao; Kun Zang; Yu Liang; Lei Cui; Yafang Hu; Ranran Cheng; Xiaolong Zhang; Juming Zhong; Huazhen Liu
Journal:  Int J Genomics       Date:  2019-04-21       Impact factor: 2.326

5.  Revision of ICH S8 Needed?

Authors:  Jan Willem Van Der Laan
Journal:  Front Toxicol       Date:  2022-04-25

6.  Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials.

Authors:  Anne M C M Doedée; Greet J Boland; Jeroen L A Pennings; Arja de Klerk; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker; Henk van Loveren; Riny Janssen
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.